Cyclins control the activity of cyclin-dependent kinases, which drive cell cycle progression. The expression of cyclins can be disrupted in cancer cells, and this Opinion article discusses the possibility that altered subcellular localization of cyclins may also affect cell cycle progression and genomic stability.